Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Electromagnetic energy from wound dressing paste can disrupt skin lipid droplets, possibly affecting cancer development.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Ficus carica leaf extract may help treat melanoma by promoting cancer cell death without harming normal cells.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.